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ABSTRACT   Emerging in December, 2019, SARS-CoV-2 is spreading worldwide, endangering 
the citizens of the globe. The authors sought to develop a feasible real-time RT-PCR method 
to detect RNA of the virus. The fluorescent probe the authors designed proved its potency 
and utility, by detecting in vitro  transcribed RNA sequence at an estimated concentration 
approximating a single copy per reaction, used along with 3 sets of primers that flank the probe 
sequence. Though not tested against actual viral RNA, or clinical specimens, this method can 
serve as another choice of rapid detection of the plague-causing virus.
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〈Regular Article〉
INTRODUCTION
   Since its emergence in December, 2019１）, 
infections including fatal pneumonia coronavirus 
disease 2019 (COVID-19), caused by severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2), 
is endangering the citizens of the globe２）. Japan, 
a neighboring country of the People’s Republic of 
China, where the plague made its first appearance, 
is currently under threat of the plague as well. A 
number of detection methods for SARS-CoV-2, 
mostly based on nucleic acid amplification, are 
reported in the literature３－５）. Still, their results are 
sometimes misinterpreted.
   The authors sought to develop another method 
to detect SARS-CoV-2, using real-time RT-PCR, 
to serve as a means of further confirmation of 
ambiguous results.
STUDY DESIGN
Primers/Probe for Real-Time RT-PCR
   All sequences of oligonucleotides employed in 
this study are presented in the Table 1.
   Four reverse primers (RevB-E) to be paired with 
the forward primer (Fwd1) sequence adopted from 
previous literature３） as well as a candidate probe 
sequence (Probe) were designed. Two more primer 
sets of shorter amplicons, employing the same 
probe were also designed (Fwd2 and RevF, Fwd3 
and RevG). The specificity of all primer pairs were 
confirmed by Primer BLAST search (https://www.
ncbi.nlm.nih.gov/tools/primer-blast/index.cgi) 
against NCBI Transcript Reference Sequences. All 
pairs except Fwd1/RevA were evaluated as specific 
to the intended template sequence; concerning 
pair Fwd1/RevA, potential target sequence from 
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MEGA script T7 kit (Thermo Fisher Scientific, 
Inc.), according to the manufacturer’s instruction, 
positive control RNA was synthesized in a 50μL 
reaction. The reaction was further processed using 
MEGA clear kit (Thermo Fisher Scientific, Inc.) 
according to the manufacturer-supplied instructions, 
to remove contaminants from the transcribed RNA. 
A small aliquot of the cleared transcribed RNA 
was electrophoresed on Agilent 4200 TapeStation 
(Agilent Technologies, Inc., Santa Clara, CA, 
USA), which showed a single band approximating 
the estimated size (856nts). The concentration of 
the cleared transcribed RNA was determined by 
NanoDrop One (Thermo Fisher Scientific, Inc.), 
which was converted into molecules (RNA copies) 
per volume (1,705.4 ng/μL  3.54×1012 copies/
μL); the RNA solution was first diluted to 1×
1012 copies/μL using THE RNA storage solution 
(Thermo Fisher Scientific, Inc.), from which 10-
fold serial dilutions down to 1×100 copies/μL 
were prepared using 0.5μg/μL Poly(A) solution as 
diluent.
REAL-TIME RT-PCR REACTIONS
   Real-Time RT-PCR reaction tests were carried out 
on CFX96 Detection System (Bio-Rad Laboratories, 
Table 1. Oligonucleotides employed in this study














underline indicates T7 RNA polymerase promoter sequence; Italic indicates first nucleotide of in vitro transcribed 
RNA sequence
＊ according to Reference sequence MN908947.3
† adopted from Reference[3]
an arthropod was suggested. Primers were ordered 
from Eurofin Genomics K.K. (Tokyo, Japan), and 
the common fluorescent probe was ordered from 
Life Technologies Japan Ltd. (Tokyo, Japan). 
POSITIVE CONTROLS
   Having no access to positive clinical specimens 
nor cultured virus, the authors used artificial 
gene synthesis to obtain an alternative. A plasmid 
harboring a small portion of the virus genome 
(nts 24199-25054 according to MN908947.3) 
was ordered from Eurofin Genomics. A trace 
amount of this plasmid served as a template for 
PCR amplification using a forward primer with a 
T7 RNA polymerase promoter sequence (ivtFwd) 
and a reverse primer (ivtRev); PrimeScript HS 
premix (TaKaRa Bio, Inc., Shiga, Japan) was 
used for this amplification. The PCR product 
was purified by gel extraction using NucleoSpin 
Gel and PCR Clean-up (Machery-Nagel GmbH, 
Düren, Germany), reconstituted in manufacturer-
provided Elution buffer (5mM Tris/HCl, pH 8.5). 
The DNA concentration of this eluate was estimated 
by NanoDrop One (Thermo Fisher Scientific, Inc., 
Madison, WI, USA). A portion of this eluate served 
as the template for in vitro transcription. Using 
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Hercules, CA, USA). The tests were prepared 
using One Step PrimeScript III RT-qPCR Mix 
(TaKaRa Bio, Inc.), in a final reaction volume of 
20μL; the final concentrations of forward primer, 
reverse primer, and fluorescent probe were 0.2
μM each; 4μL of template solution was applied 
to each reaction. Thermal conditions were: 52℃ 
5min; 95℃ 10s; 60 cycles of 95℃ 5s and 60℃
30s. These concentrations and temperatures are the 
default values given in the manufacturer-provided 
protocol. To assess the chances of unintended rise in 
fluorescence, amplification cycles were increased to 
60 cycles.
   For selecting candidate primers, serial dilutions 
of positive control RNAs of 1×103,2,1,0 copies/
μL were used; for detection limit confirmation, 
serial 2-fold dilutions of 8,4,2,1×100 copies per 
reaction were prepared and subjected to detection. 
In this case the last two concentrations were carried 
out in triplicates and negative control reactions in 
duplicates.
RESULTS
   Among the 7 primer pairs tested, all but the pair 
Fwd3/RevG proved their potency in detecting RNA 
of 4×100 copies per 20μL reaction (Fig. 1A, 1B). 
Furthermore, no rise in fluorescence was detected 
in negative control reactions by 60 amplification 
cycles. Three primer pairs Fwd1/RevA (product 
547bp), Fwd1/RevC (product 517bp), Fwd2/RevF 
(product 166bp) were further tested for detection 
limits, all of which succeeded in discovering at 
least one reaction among triplicates of 1×100 copy 
per reaction within 41 amplification cycles (Fig. 
1C~1H).
DISCUSSIONS
   We have succeeded in developing another real-
time RT-PCR method to detect SARS-CoV-2 RNA 
sequence. Though a number of similar methods are 
reported in the literature３－５）, our method proved its 
potency in detecting one copy per reaction among 
triplicates. Since the actual number of template 
molecules under concentrations approximating 
single molecules per reaction is known to follow 
a Poisson distribution, 13.5% of reactions of an 
estimated two copies per reaction, 36.8% of one 
copy per reaction may have no templates. Thus, 
negative reactions among the triplicates are not to 
be considered as differences in the primer sets’ 
potentials but rather as a natural behavior of single 
molecule reactions. Furthermore, no unexpected 
reaction was observed even after 60 amplification 
cycles, suggesting a low possibility of false positive 
reactions.
   The reagent being a premix of buffer, dNTP, DNA 
polymerase and reverse transcriptase, remaining 
unfrozen at -20℃, the reaction could be set up 
rapidly and feasibly, with less complication. This 
feature might reduce laboratory workers’ burdens, 
as well as chances of human error throughout the 
detection procedure.
   The fluorescent probe and reaction condition is 
shared among the primer pairs. Thus, in the case 
of suspected mutations of the viral sequence at 
annealing position of a certain primer pair, other 
primer pairs can readily serve a complementary 
role to each other. Shared fluorescent probe reduces 
the monetary cost and time for preparing another 
backup assay; shared reaction condition abolishes 
the risk of confusion among multiple thermal 
cycling programs.
   One of the successful primer pairs (Fwd1/
RevA) was adopted from the literature３）, which is 
currently used as the outer primer set of a nested 
RT-PCR detection procedure employing gel 
electrophoresis listed in the domestic SARS-CoV-2 
detection manual４）. Employing the aforementioned 
fluorescent probe might help abolish the second 
PCR and electrophoresis procedures in laboratories 
formerly employing the nested PCR procedure, 
without wasting the outer primers.
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Fig. 1. Amplification plot of each primer set.
X-axis, amplification cycles; Y-axis, relative fluorescent units; NC, negative control. 
Panels A), B) 7sets against 4 × 101, 4 × 100 copies per reaction respectively; C), D), primer Fwd1/RevA; E), F) primer 
Fwd1/RevC; G), H) primer Fwd2/RevF. Panels C), E), G) against controls 4 × 103 to 4 × 100 copies per reaction; D), F), 
H) against controls 8 × 100 to 1 × 100 copies per reaction. The numbers n/m in the legends of panels D), F), H) denotes the 
number of positive reactions among multiplicates.
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   The authors are aware of the following limitations. 
The assay was tested against artificial RNA controls, 
since experiments using actual viral RNA controls 
could not be carried out, due to inaccessibility. 
Although a few clinical specimens from both our 
institute and the Kawasaki Medical School General 
Medical Center were provisionally analyzed by 
the assay, no specimens proved positive, which 
was completely concordant with the authorized 
analysis results from the Prefectural Institute 
for Environmental Science and Public Health. 
Furthermore, institutional ethical policies hindered 
the authors from immediately carrying out specific 
studies employing nucleic acid extracts derived 
from clinical specimens known to be positive for 
other causative agents of respiratory infections. 
Evaluations utilizing such clinical specimens are 
warranted.
   The reaction conditions might not be optimal, 
though the default reaction conditions from the 
manufacturer-provided protocol proved practical.
   The concentration of our artificial control 
RNA, determined by optical density, might be 
misunderstood to be prone to overestimation 
among colleagues used to fluorescence-based 
quantitation. Overestimation tends to occur 
when RNA concentrations are faint, and/or with 
contaminants, which is unlikely in our case which 
quantitated concentrated RNA of 1.7μg/μL, 
cleared from contaminants using silica-based 
columns. Furthermore, overestimated control RNA 
concentration will underestimate the detection limit, 
the prudent side for detecting trace amounts of 
target molecules.
   The emerging disease caused by SARS-CoV-2 is 
still spreading over the globe, across boundaries. 
Demands for clinically available tests are rising. 
Our method, bearing capability of detecting as trace 
as a single copy target per reaction, and robustness/
flexibility against target sequence mutations, might 
serve as another means of meeting such demands. 
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